Showing results (41-50 of 111) with videos related to
Sort By:
Pageof 12
Journal of Virology|October 9, 2023
Mosaic HIV-1 vaccination induces anti-viral CD8+ T cell functionality in the phase 1/2a clinical trial APPROACHJanine van Duijn, Daniel Stieh, Natalia Fernandez, et al.Open Forum Infectious Diseases|April 1, 2024
HLA-A*23 Is Associated With Lower Odds of Acute Retroviral Syndrome in Human Immunodeficiency Virus Type 1 Infection: A Multicenter Sub-Saharan African StudyLovisa Lindquist, William Kilembe, Etienne Karita, et al.Frontiers in Microbiology|October 25, 2021
Increased Frequency of Inter-Subtype HIV-1 Recombinants Identified by Near Full-Length Virus Sequencing in Rwandan Acute Transmission CohortsGisele Umviligihozo, Erick Muok, Emmanuel Nyirimihigo Gisa, et al.Virology|April 17, 2015
Canine distemper virus neutralization activity is low in human serum and it is sensitive to an amino acid substitution in the hemagglutinin proteinXinsheng Zhang, Olivia L Wallace, Arban Domi, et al.Frontiers in Microbiology|August 27, 2025
Comparison of viral phenotype and inflammatory biomarker responses in acute HIV-1 subtype A and C infectionsSamantha McInally, Daniel T Claiborne, Elina El-Badry, et al.Journal of Immunological Methods|December 3, 2013
Development of a luciferase based viral inhibition assay to evaluate vaccine induced CD8 T-cell responsesMarloes A Naarding, Natalia Fernandez, John C Kappes, et al.Plos One|August 30, 2018
Induction of circulating T follicular helper cells and regulatory T cells correlating with HIV-1 gp120 variable loop antibodies by a subtype C prophylactic vaccine tested in a Phase I trial in IndiaSivasankaran Munusamy Ponnan, Soumya Swaminathan, Kannan Tiruvengadam, et al.Journal of Virology|July 1, 2011
Human leukocyte antigen variants B*44 and B*57 are consistently favorable during two distinct phases of primary HIV-1 infection in sub-Saharan Africans with several viral subtypesJianming Tang, Emmanuel Cormier, Jill Gilmour, et al.Plos One|March 29, 2019
Induction and maintenance of bi-functional (IFN-γ + IL-2+ and IL-2+ TNF-α+) T cell responses by DNA prime MVA boosted subtype C prophylactic vaccine tested in a Phase I trial in IndiaSivasankaran Munusamy Ponnan, Sathyamurthy Pattabiram, Kannan Thiruvengadam, et al.Plos Pathogens|August 25, 2015
HLA Class-II Associated HIV Polymorphisms Predict Escape from CD4+ T Cell ResponsesNathan Erdmann, Victor Y Du, Jonathan Carlson, et al.Pageof 12